PANTR1 and central nervous system cancer: Collectively, the nomogram we constructed proved that PANTR1 could serve as a potential biomarker of glioma prognosis, as high expression of PANTR1 may confer a variety of adverse events at the molecular level, especially in those with grade II/III gliomas.